These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23282127)

  • 1. Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.
    Davis JT; Pasha DN; Khandrika S; Fung MM; Milic M; O'Connor DT
    J Clin Hypertens (Greenwich); 2013 Jan; 15(1):69-74. PubMed ID: 23282127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
    Briasoulis A; Oliva R; Kalaitzidis R; Flynn C; Lazich I; Schlaffer C; Bakris G
    J Clin Hypertens (Greenwich); 2013 Jul; 15(7):473-9. PubMed ID: 23815535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study.
    Vaz-de-Melo RO; Giollo-Júnior LT; Martinelli DD; Moreno-Júnior H; Mota-Gomes MA; Cipullo JP; Yugar-Toledo JC; Vilela-Martin JF
    Sao Paulo Med J; 2014; 132(5):290-6. PubMed ID: 25054966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
    Vitale C; Marazzi G; Iellamo F; Spoletini I; Dall'Armi V; Fini M; Volterrani M
    Int J Cardiol; 2012 Mar; 155(2):279-84. PubMed ID: 22078979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
    Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J
    Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A; Punzi H; Luo X; Stapff M
    Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
    Kamp O; Metra M; Bugatti S; Bettari L; Dei Cas A; Petrini N; Dei Cas L
    Drugs; 2010; 70(1):41-56. PubMed ID: 20030424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE; DiGennaro F; Giani JF; Dominici FP
    Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol efficacy and safety in patients with stage I-II hypertension.
    Greathouse M
    Clin Cardiol; 2010 Apr; 33(4):E20-7. PubMed ID: 20162736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.
    Van Nueten L; Lacourcière Y; Vyssoulis G; Korlipara K; Marcadet DM; Dupont AG; Robertson JI
    Am J Ther; 1998 Jul; 5(4):237-43. PubMed ID: 10099065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of atenolol and nebivolol in isolated systolic hypertension.
    Dhakam Z; Yasmin ; McEniery CM; Burton T; Brown MJ; Wilkinson IB
    J Hypertens; 2008 Feb; 26(2):351-6. PubMed ID: 18192850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
    Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW; Lin Y; Pejović V; Bowen L
    Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial.
    Giles TD; Khan BV; Lato J; Brener L; Ma Y; Lukic T
    J Clin Hypertens (Greenwich); 2013 Sep; 15(9):687-93. PubMed ID: 24034663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial stiffness, hypertension, and rational use of nebivolol.
    Agabiti-Rosei E; Porteri E; Rizzoni D
    Vasc Health Risk Manag; 2009; 5(1):353-60. PubMed ID: 19475771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
    Merchant N; Searles CD; Pandian A; Rahman ST; Ferdinand KC; Umpierrez GE; Khan BV
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):720-5. PubMed ID: 20021529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.